Anti-Granzyme B antibody [EPR8260] - Mouse IgG1 (Chimeric)
- BOND RX™ Validated
- 20ul selling size
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(2 Publications)
Mouse Recombinant Monoclonal Granzyme B antibody. Suitable for WB, IHC-P and reacts with Human samples. Cited in 2 publications.
View Alternative Names
CGL1, CSPB, CTLA1, GRB, GZMB, Granzyme B, C11, CTLA-1, Cathepsin G-like 1, Cytotoxic T-lymphocyte proteinase 2, Fragmentin-2, Granzyme-2, Human lymphocyte protein, SECT, T-cell serine protease 1-3E, CTSGL1, Lymphocyte protease, HLP
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Granzyme B antibody [EPR8260] - Mouse IgG1 (Chimeric) (AB283315)
Immunohistochemical analysis of paraffin-embedded human tonsil tissue labeling Granzyme B with ab283315 at 1/500 (2.114 μg/ml) dilution followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).
Positive staining on human tonsil (PMID : 29042640).
The section was incubated with ab283315 for 30 mins at room temperature and followed by mouse specific IgG antibody (ab125913) for 8 mins. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with Hematoxylin.
Secondary antibody only control : Secondary antibody is a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).
Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 mins.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Granzyme B antibody [EPR8260] - Mouse IgG1 (Chimeric) (AB283315)
Immunohistochemical analysis of paraffin-embedded human Hodgkin's lymphoma tissue labeling Granzyme B with ab283315 at 1/500 (2.114 μg/ml) dilution followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).
Positive staining on human Hodgkin's lymphoma.
The section was incubated with ab283315 for 30 mins at room temperature and followed by mouse specific IgG antibody (ab125913) for 8 mins. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with Hematoxylin.
Secondary antibody only control : Secondary antibody is a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).
Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 mins.
- WB
Lab
Western blot - Anti-Granzyme B antibody [EPR8260] - Mouse IgG1 (Chimeric) (AB283315)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
Negative control : Jurkat (PMID : 18437383, 25168906).
Exposure time : 15 seconds.
All lanes:
Western blot - Anti-Granzyme B antibody [EPR8260] - Mouse IgG1 (Chimeric) (ab283315) at 1/1000 dilution
Lane 1:
KARPAS-299 (human anaplastic large cell lymphoma), whole cell lysate at 20 µg
Lane 2:
Jurkat (human T cell leukemia T lymphocyte), whole cell lysate at 20 µg
Lane 3:
SR (human pleural effusion lymphoblast, whole cell lysate at 20 µg
Secondary
All lanes:
Peroxidase-Conjugated Goat anti-Mouse IgG (H+L) at 1/5000 dilution
Predicted band size: 28 kDa
Observed band size: 28 kDa
false
Reactivity data
Product details
This mouse monoclonal chimeric antibody has been engineered from a RabMAb parent antibody (ab134933). By necessity, some rabbit sequence is retained as part of the variable domain. When multiplexing with other rabbit-derived antibodies, using cross absorbed Fc-reactive secondary antibodies are recommended.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Granzyme B participates prominently in the immune response by activating caspases particularly caspase-3 which promotes the breakdown of cellular components necessary for apoptosis. Granzyme B does not function in isolation but acts in concert with other immune system factors such as perforin to effectively induce cell death. Perforin creates pores in the target cell membrane allowing granzyme B to enter and instigate the apoptosis sequence. The enzyme also contributes to the processing of cytokines which enhances the immune response further.
Pathways
Studies have determined that granzyme B is critical in the apoptosis pathway particularly in the granule exocytosis pathway. It closely interacts with proteins such as perforin and other granzymes to mediate apoptosis in target cells. Granzyme B also plays a role in the inflammatory response and can influence pathways associated with cytotoxic T cell signaling. Its pathway interactions ensure effective elimination of damaged or infected cells maintaining tissue homeostasis.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (2)
Recent publications for all applications. Explore the full list and refine your search
Journal of the National Cancer Center 5:221-235 PubMed40265092
2025
Applications
Unspecified application
Species
Unspecified reactive species
World journal of surgical oncology 22:128 PubMed38725005
2024
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com